Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China · Delayed Price · Currency is CNY 11.97
-0.01 (-0.08%)
Oct 23, 2026, 3:00 PM CST
SHA:603079 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 832.86 | 844.54 | 827.4 | 727.41 | 738.02 | 789.73 |
Revenue Growth | -1.28% | 2.07% | 13.75% | -1.44% | -6.55% | -8.95% |
Gross Profit Gross Profit Growth | 206.36 | 209.64 | 163.6 | 74.18 | 110.27 | 216.33 |
Operating Income Operating Income Growth | 55.12 | 67.07 | 31.54 | -54.48 | -10.07 | 60.49 |
Net Income Net Income Growth | 44.88 | 62.16 | 29.42 | -54.06 | 31.48 | 75.76 |
Earnings Per Share EPS Growth | 0.24 | 0.35 | 0.17 | -0.32 | 0.18 | 0.44 |
EPS Growth | -15.58% | 105.88% | - | - | -59.09% | -62.39% |
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Vitamins Vitamins Growth | 231.38 | 224.21 | 244.71 |
Biological Preservatives and Functional Ingredients Biological Preservatives and Functional Ingredients Growth | 505.44 | 524.74 | 489.31 |
External Steam Sales External Steam Sales Growth | 18.46 | 20.18 | 37.19 |
Others Others Growth | 73.71 | 71.53 | 55.4 |
Sales Materials Sales Materials Growth | - | 3.87 | 0.79 |
Total Total Growth | 832.86 | 844.54 | 827.4 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 626.35 | 650.31 | 345.63 | 326.74 | 330.72 | 534.83 |
Total Debt Total Debt Growth | 339.14 | 324.86 | 263.23 | 239.2 | 42.65 | 168.85 |
Net Cash (Debt) Net Cash Growth | 287.22 | 325.45 | 82.4 | 87.54 | 288.07 | 365.98 |
Net Cash Growth | - | 294.95% | -5.86% | -69.61% | -21.29% | -18.70% |
Net Cash Per Share Net Cash Per Share Growth | 1.55 | 1.83 | 0.48 | 0.52 | 1.65 | 2.13 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 126.65 | 138.88 | 147.88 | 64.42 | 40.72 | 74.46 |
Capital Expenditures CapEx Growth | -125.68 | -145.68 | -169.85 | -245.93 | -63.26 | -99.96 |
Free Cash Flow Free Cash Flow Growth | 0.97 | -6.8 | -21.97 | -181.51 | -22.54 | -25.5 |
Free Cash Flow Growth | -90.05% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 24.78% | 24.82% | 19.77% | 10.20% | 14.94% | 27.39% |
Operating Margin | 6.62% | 7.94% | 3.81% | -7.49% | -1.36% | 7.66% |
Pretax Margin | 7.41% | 9.49% | 5.93% | -6.23% | 4.95% | 10.14% |
Profit Margin | 5.39% | 7.36% | 3.56% | -7.43% | 4.27% | 9.59% |
FCF Margin | 0.12% | -0.80% | -2.66% | -24.95% | -3.05% | -3.23% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | - | 0.060 | 0.060 | 0.140 |
Dividend Per Share Growth | 0% | - | - | 0% | -57.14% | -60.00% |
Dividend Yield | 0.84% | 0.56% | - | 0.41% | 0.48% | 0.81% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 49.34 | 53.36 | 77.51 | - | 68.24 | 39.09 |
Forward PE | - | 55.60 | 55.60 | 55.60 | 55.60 | 55.60 |
PS Ratio | 2.69 | 3.93 | 2.76 | 3.42 | 2.91 | 3.75 |